IHAM
Integral Health Asset Management’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.75M | Sell |
700,000
-225,000
| -24% | -$1.85M | 0.53% | 47 |
|
|
2025
Q1 | $6.61M | Buy |
925,000
+25,000
| +3% | +$179K | 0.7% | 41 |
|
|
2024
Q4 | $6.96M | Sell |
900,000
-375,000
| -29% | -$2.9M | 0.59% | 52 |
|
|
2024
Q3 | $13.4M | Buy |
1,275,000
+325,000
| +34% | +$3.41M | 1.5% | 18 |
|
|
2024
Q2 | $11.1M | Buy |
950,000
+190,000
| +25% | +$2.22M | 1.06% | 30 |
|
|
2024
Q1 | $16M | Buy |
760,000
+435,000
| +134% | +$9.17M | 1.49% | 23 |
|
|
2023
Q4 | $5.83M | Buy |
+325,000
| New | +$5.83M | 0.79% | 51 |
|
|
2022
Q2 | – | Sell |
-90,000
| Closed | -$2.99M | – | 82 |
|
|
2022
Q1 | $2.99M | Buy |
90,000
+15,000
| +20% | +$498K | 0.78% | 46 |
|
|
2021
Q4 | $2.45M | Buy |
75,000
+20,000
| +36% | +$654K | 0.68% | 45 |
|
|
2021
Q3 | $2.31M | Buy |
+55,000
| New | +$2.31M | 0.66% | 52 |
|